Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System

Hepatocellular carcinoma (HCC) is a highly malignant tumor related to high mortality and is still lacking a satisfactory cure. Tumor metastasis is currently a major challenge of cancer treatment, which is highly related to angiogenesis. The vascular endothelial growth factor (VEGF)/VEGFR signaling p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xunan, Wang, Xiang, Liu, Nian, Wang, Qiuyu, Hu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000533/
https://www.ncbi.nlm.nih.gov/pubmed/35408480
http://dx.doi.org/10.3390/molecules27072082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000533/
https://www.ncbi.nlm.nih.gov/pubmed/35408480
http://dx.doi.org/10.3390/molecules27072082

Ejemplares similares